Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for nucleoside reverse transcriptase inhibitors (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
- Drug target sets for approved compounds
- Liver Pharmacology and Xenobiotic Response Repertoire
Most Relevant Literature
- Nevirapine bioactivation and covalent binding in the skin.
- Solid dosage forms for active antiretroviral therapy (HAART): dissolution profile study of nevirapin…
- Hyperhidrosis related to nevirapine therapy.
- Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapa…
- Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in brea…
Most Relevant Clinical Trials
- Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)…
- Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
- Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhib…
- TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efa…
- A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retr…
